Randomized phase III trial evaluating motivational interviewing and text interventions to optimize adherence to breast cancer endocrine therapy (Alliance A191901): the GETSET protocol
Abstract Background Hormone receptor-positive (HR +) breast cancer is the most common type of breast cancer in the USA but has excellent long-term outcomes in recent decades, in part due to effective oral endocrine therapy (ET). ET medications are typically prescribed for 5 to 10 years, depending on...
Main Authors: | Joannie Ivory, Stephanie B. Wheeler, Sarah Drier, Heather Gunn, David Zahrieh, Electra Paskett, Michelle Naughton, Rachel Wills, Kayla Swetel, Selina Chow, Katherine Reeder-Hayes |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-023-07672-8 |
Similar Items
-
Motivational Interviewing Counseling to Increase Endocrine Therapy Adherence in Diverse Patients
by: Stephanie B. Wheeler, et al.
Published: (2023-03-01) -
Genetic diagnosis of endocrine disorders /
by: Weiss, Roy E., et al.
Published: (c201) -
Screening for endocrine hypertension. An Endocrine Society scientific statement
by: William F. Young Jr., et al.
Published: (2017-12-01) -
Endocrine-Disrupting Chemicals and Disease Endpoints
by: Changhwan Ahn, et al.
Published: (2023-03-01) -
Viruses and Endocrine Diseases
by: Magloire Pandoua Nekoua, et al.
Published: (2023-01-01)